Cargando…

Punicalagin Exerts Protective Effects against Ankylosing Spondylitis by Regulating NF-κB-TH17/JAK2/STAT3 Signaling and Oxidative Stress

BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by sacroiliitis and spinal rigidity of the axial joints. The role of oxidative stress and increased proinflammatory cytokines is well documented in AS pathogenesis. Punicalagin (2,3-hexahydroxydiphenoyl-gallagyl-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Xinzhe, Yang, Qinyuan, Wang, Chen, Tong, Wenwen, Xu, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532417/ https://www.ncbi.nlm.nih.gov/pubmed/33029510 http://dx.doi.org/10.1155/2020/4918239

Ejemplares similares

IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
por: Jo, Sungsin, et al.
Publicado: (2018)

CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro
por: Feng, Xinzhe, et al.
Publicado: (2023)

Role of HLA-B27 in the pathogenesis of ankylosing spondylitis
por: Chen, Bin, et al.
Publicado: (2017)

Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
por: Hammitzsch, Ariane, et al.
Publicado: (2018)

Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021)

Curculigoside exerts significant anti-arthritic effects in vivo and in vitro via regulation of the JAK/STAT/NF-κB signaling pathway
por: Tan, Shirui, et al.
Publicado: (2019)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
por: Milanez, Fernanda Manente, et al.
Publicado: (2016)

Looking Beyond Th17 Cells: A Role for Tr1 Cells in Ankylosing Spondylitis?
por: McGinty, Joanna, et al.
Publicado: (2020)

Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF-κB signaling
por: Huang, Tao, et al.
Publicado: (2020)

Ankylosing spondylitis: analysis of gene-gene interactions between IL-12β, JAK2, and STAT3 in Han Chinese and Algerian cohorts
por: Saadi, Ahlem, et al.
Publicado: (2019)

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways
por: Wang, Wei, et al.
Publicado: (2020)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Micheliolide alleviates ankylosing spondylitis (AS) by suppressing the activation of the NLRP3 inflammasome and maintaining the balance of Th1/Th2 via regulating the NF-κB signaling pathway
por: Tian, Zhong-Gu, et al.
Publicado: (2020)

Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis
por: He, Tao, et al.
Publicado: (2017)

Increased Frequencies of Th22 Cells as well as Th17 Cells in the Peripheral Blood of Patients with Ankylosing Spondylitis and Rheumatoid Arthritis
por: Zhang, Lei, et al.
Publicado: (2012)

Clinical Significance of Peripheral Blood Th1 and Th17 Cell Content and Serum IL-35 and IL-17 Expression in Patients with Ankylosing Spondylitis
por: Tan, Haitao, et al.
Publicado: (2022)

Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis
por: Klasen, Charlotte, et al.
Publicado: (2019)

Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
por: Moon, Jeonghyeon, et al.
Publicado: (2022)

Aconiti lateralis radix praeparata total alkaloids exert anti-RA effects by regulating NF-κB and JAK/STAT signaling pathways and promoting apoptosis
por: Wu, Yeke, et al.
Publicado: (2022)

Retracted: Clinical Significance of Peripheral Blood Th1 and Th17 Cell Content and Serum IL-35 and IL-17 Expression in Patients with Ankylosing Spondylitis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Expression of long non‑coding RNA NONHSAT227927.1 and its effect on the JAK2/STAT3 signaling pathway and inflammation in patients with ankylosing spondylitis
por: Ding, Xiang, et al.
Publicado: (2023)

Update on the treatment of ankylosing spondylitis
por: Maksymowych, Walter P
Publicado: (2007)

Ankylosing spondylitis: yesterday and today.
por: Spencer, D G, et al.
Publicado: (1980)

Treat Ankylosing Spondylitis with Methazolamide
por: Chang, Xiaotian, et al.
Publicado: (2011)

Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007)

Ankylosing Spondylitis and Cardiac Abnormalities
por: Yang, Dong Heon
Publicado: (2012)

Cardiopulmonary Manifestations of Ankylosing Spondylitis
por: Momeni, Mahnaz, et al.
Publicado: (2011)

Spinal instability in ankylosing spondylitis
por: Badve, Siddharth A, et al.
Publicado: (2010)

Microbes, the gut and ankylosing spondylitis
por: Costello, Mary-Ellen, et al.
Publicado: (2013)

Advances in managing ankylosing spondylitis
por: Daikh, David I., et al.
Publicado: (2014)

Trends of Ankylosing Spondylitis Ossification
por: Rozin, Alexander P
Publicado: (2013)

Cardiac Involvement in Ankylosing Spondylitis
por: Ozkan, Yasemin
Publicado: (2016)

Predictors of Atherosclerosis in Ankylosing Spondylitis
por: Verma, Inderjeet, et al.
Publicado: (2015)

Medical Treatment of Ankylosing Spondylitis
por: Moon, Kyoung-Ho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n1egtq5mm4ff50hmmsfc9jqtfd